tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

ENDRA Life Sciences Inc

NDRA
Add to Watchlist
4.610USD
+0.280+6.47%
Close 07-31 16:00（ET）Quotes delayed by 15 min
5.42MMarket Cap
LossP/E TTM

ENDRA Life Sciences Inc

4.610
+0.280+6.47%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

NDRA Financials

See ENDRA Life Sciences Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

ENDRA Life Sciences Inc Earnings Date

Latest Release
May 15, 2026
EPS / Forecast
-1.09/-1.23
Revenue / Forecast
--/0.00
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-8.93
84.32%
Analyst Rating
BUY
2026/07/31
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
41.18%-1.09
62.88%-2.85
99.37%-2.10
98.80%-1.71
99.59%-1.86
97.42%-7.69
52.73%-333.82
80.84%-142.97
72.33%-449.57
83.61%-298.31
---706.20
---746.30
---1.62K
---1.82K
---6.18K
----
----
----
----
----
Net Profit
-26.55%-1.31M
23.62%-3.17M
32.20%-1.60M
45.01%-1.23M
62.66%-1.04M
-184.27%-4.15M
24.08%-2.35M
12.83%-2.23M
5.68%-2.78M
55.63%-1.46M
9.87%-3.10M
28.79%-2.56M
-2.96%-2.94M
-5.96%-3.29M
-29.42%-3.44M
-12.25%-3.59M
-19.57%-2.86M
-37.94%-3.10M
27.24%-2.66M
-10.55%-3.20M
Debt to assets ratio
----
----
----
----
----
-100.00%0.00%
-100.00%0.00%
-100.00%0.00%
-100.00%0.00%
37.31%0.42%
--0.37%
--0.31%
--0.43%
--0.31%
--0.23%
----
----
----
----
----
Income Statement
Operating profit
-47.95%-2.17M
62.25%-1.62M
9.17%-1.37M
41.68%-1.30M
47.16%-1.47M
-194.75%-4.30M
51.77%-1.51M
25.50%-2.23M
5.40%-2.78M
56.00%-1.46M
8.43%-3.13M
16.16%-2.99M
-2.94%-2.94M
-7.87%-3.31M
-28.92%-3.42M
-11.61%-3.57M
-10.85%-2.86M
-36.25%-3.07M
18.58%-2.65M
-10.68%-3.20M
Net Profit
-26.55%-1.31M
23.62%-3.17M
32.20%-1.60M
45.01%-1.23M
62.66%-1.04M
-184.27%-4.15M
24.08%-2.35M
12.83%-2.23M
5.68%-2.78M
55.63%-1.46M
9.87%-3.10M
28.79%-2.56M
-2.96%-2.94M
-5.96%-3.29M
-29.42%-3.44M
-12.25%-3.59M
-19.57%-2.86M
-37.94%-3.10M
27.24%-2.66M
-10.55%-3.20M
Balance Sheet
Current assets
-75.38%536.67K
-71.81%967.97K
-78.87%1.05M
-72.40%1.85M
71.60%2.18M
13.22%3.43M
-22.44%4.96M
-16.95%6.71M
-76.98%1.27M
-43.62%3.03M
-44.68%6.40M
-44.20%8.08M
-45.46%5.52M
-55.52%5.38M
-20.08%11.56M
-11.35%14.49M
-44.86%10.12M
47.35%12.09M
202.75%14.47M
618.27%16.34M
Total current liabilities
47.66%835.44K
24.08%750.96K
-1.69%800.31K
-57.29%576.64K
-53.50%565.78K
-32.98%605.23K
-62.48%814.04K
-33.59%1.35M
-33.58%1.22M
-46.99%903.10K
27.23%2.17M
35.32%2.03M
34.89%1.83M
10.36%1.70M
8.14%1.71M
-8.28%1.50M
77.32%1.36M
56.46%1.54M
12.74%1.58M
32.07%1.64M
Total assets
8.44%3.44M
-13.44%3.85M
-76.56%1.96M
-73.11%2.81M
-37.35%3.17M
-34.08%4.45M
10.21%8.38M
12.96%10.44M
-23.96%5.06M
-27.17%6.75M
-38.40%7.60M
-39.61%9.24M
-39.15%6.65M
-27.97%9.27M
-19.40%12.34M
-11.21%15.31M
-42.13%10.94M
46.89%12.87M
185.65%15.31M
502.33%17.24M
Total liabilities
16.48%1.65M
-15.77%1.59M
1.03%1.79M
-7.87%1.33M
4.05%1.42M
72.76%1.89M
-26.27%1.77M
-37.40%1.45M
-36.80%1.36M
-47.08%1.10M
12.49%2.41M
17.17%2.31M
15.41%2.16M
-0.99%2.07M
-0.87%2.14M
-12.33%1.98M
78.48%1.87M
31.01%2.09M
6.51%2.16M
19.46%2.25M
Total equity
1.94%1.79M
-11.73%2.26M
-97.41%171.38K
-83.62%1.47M
-52.60%1.75M
-54.76%2.56M
27.10%6.60M
29.77%8.99M
-17.80%3.70M
-21.45%5.66M
-49.07%5.20M
-48.02%6.93M
-50.39%4.50M
-33.19%7.20M
-22.44%10.20M
-11.04%13.33M
-49.20%9.07M
50.42%10.78M
294.49%13.16M
1434.47%14.99M
Cash Flow Statement
Net operating income
13.42%-1.12M
-6.33%-1.61M
29.76%-1.16M
46.54%-1.11M
39.69%-1.29M
30.30%-1.52M
36.23%-1.66M
8.17%-2.08M
14.46%-2.14M
29.60%-2.17M
19.96%-2.60M
31.98%-2.27M
19.10%-2.51M
-16.43%-3.09M
-18.21%-3.25M
-19.13%-3.33M
-6.00%-3.10M
-27.96%-2.65M
-28.75%-2.75M
18.90%-2.80M
Net investment
2704.17%450.00K
---3.00M
--0.00
-100.00%0.00
27.38%-17.28K
-100.00%0.00
--0.00
--11.00K
11.87%-23.80K
105.91%2.28K
100.00%0.00
100.00%0.00
69.78%-27.00K
---38.56K
---14.86K
---59.80K
-98.56%-89.35K
100.00%0.00
-100.00%0.00
--0.00
Net financing
80.89%263.75K
--4.58M
8780.93%149.47K
-88.32%857.41K
-68.91%145.80K
-100.00%0.00
-99.85%1.68K
55.05%7.34M
--468.90K
--1.67M
--1.11M
-37.28%4.73M
-100.00%0.00
-100.00%0.00
-100.00%0.00
--7.55M
-93.21%854.05K
-94.24%321.08K
-90.39%496.61K
-100.00%0.00

FAQs

What are the current assets of ENDRA Life Sciences Inc?

According to ENDRA Life Sciences Inc's FY2025 earnings report, its current assets were 967.97K, with a year-on-year change of -71.81.

What are the total assets of ENDRA Life Sciences Inc?

According to ENDRA Life Sciences Inc's FY2025 earnings report, its total assets of ENDRA Life Sciences Inc were 3.85M, with a year-on-year change of -13.44.

What are the total liabilities of ENDRA Life Sciences Inc?

According to ENDRA Life Sciences Inc's FY2025 earnings report, its total liabilities of ENDRA Life Sciences Inc were 1.59M, with a year-on-year change of -15.77.

What is the total equity of ENDRA Life Sciences Inc?

According to ENDRA Life Sciences Inc's FY2025 earnings report, its total equity of ENDRA Life Sciences Inc was 2.26M, with a year-on-year change of -11.73.

What is the net operating income of ENDRA Life Sciences Inc?

According to ENDRA Life Sciences Inc's FY2025 earnings report, its net operating income of ENDRA Life Sciences Inc was -5.76M, with a year-on-year change of 46.72.

What is the net investment of ENDRA Life Sciences Inc?

According to ENDRA Life Sciences Inc's FY2025 earnings report, its net investment of ENDRA Life Sciences Inc was -3.02M, with a year-on-year change of -23479.87.

What is the net financing of ENDRA Life Sciences Inc?

According to ENDRA Life Sciences Inc's FY2025 earnings report, its net financing of ENDRA Life Sciences Inc was 5.73M, with a year-on-year change of -26.59.

What is the Earnings Per Share (EPS) of ENDRA Life Sciences Inc?

According to ENDRA Life Sciences Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -8.93, with a year-on-year change of 84.32.

What is the net income of ENDRA Life Sciences Inc?

According to ENDRA Life Sciences Inc's FY2025 earnings report, its net income was -7.03M, with a year-on-year change of 38.93.

What is the Return on Equity (ROE) of ENDRA Life Sciences Inc?

According to ENDRA Life Sciences Inc's FY2025 earnings report, its Return on Equity (ROE) was -291.56, with a year-on-year change of -4.12.

What is the Return on Assets (ROA) of ENDRA Life Sciences Inc?

According to ENDRA Life Sciences Inc's FY2025 earnings report, its Return on Assets (ROA) was -169.21, with a year-on-year change of 17.61.

What is the operating profit of ENDRA Life Sciences Inc?

According to ENDRA Life Sciences Inc's FY2025 earnings report, its operating profit was -5.76M, with a year-on-year change of 46.72.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy